Jamie Clark
Stock Analyst at Rothschild & Co
(2.61)
# 2,088
Out of 5,024 analysts
9
Total ratings
85.71%
Success rate
10.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $262.95 | +18.27% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $514.32 | -7.84% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $187.85 | +25.63% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $170.72 | +6.61% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $282.75 | -2.39% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $187.35 | +4.08% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $203.12 | +35.88% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $262.95
Upside: +18.27%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $514.32
Upside: -7.84%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $187.85
Upside: +25.63%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $170.72
Upside: +6.61%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $282.75
Upside: -2.39%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $187.35
Upside: +4.08%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $203.12
Upside: +35.88%